Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP - News) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced the identification of a second biomarker for development of a tuberculosis assay. This is a significant milestone in the cooperative research agreement that was signed between Los Alamos National Laboratory and Biomagnetics, representing a major step in the development of a new point-of-care diagnostic system. In parallel, development of assays for two different tuberculosis biomarkers and the Cholera toxin is currently in progress. In addition to the first tuberculosis biomarker, assay development for a second biomarker has also commenced.

Clayton Hardman, CEO of Biomagnetics commented, “The hand-held version of the Integrated Optical Biosensor (“IOBS”), being developed by BioMagnetics, is specifically designed to be field deployable and ultraportable, allowing for the rapid detection of various pathogens by relatively untrained personnel outside the laboratory setting, at a lower cost than traditional diagnostic technologies. We believe these devices hold the potential to revolutionize disease detection, saving millions of lives in the process. We are clearly honored to be working with the very prestigious and highly qualified scientific staff at Los Alamos National Laboratory.”

About Biomagnetics Diagnostics Corp.

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company and an acquirer of other innovative technologies. The Company is currently developing a waveguide-based advanced integrated optical biosensor through its cooperative research and development agreement with Los Alamos National Security, LLC, which will initially be used for cholera, tuberculosis and malaria diagnosis. More information on Biomagnetics Diagnostics Corp. can be seen at www.biomagneticsbmgp.com.

Biomagnetics Diagnostics (CE) (USOTC:BMGP)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Biomagnetics Diagnostics (CE).
Biomagnetics Diagnostics (CE) (USOTC:BMGP)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Biomagnetics Diagnostics (CE).